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Abstract
Esophageal motility abnormalities are among the main 
factors implicated in the pathogenesis of gastroesopha-
geal  reflux  disease.  The  recent   introduction   in  clinical  
and research practice of novel esophageal testing has 
markedly improved our understanding of the mecha-
nisms contributing to the development of gastroesoph-
ageal  reflux  disease,  allowing  a  better  management  of  
patients  with  this  disorder.  In  this  context,  the  present  
article   intends   to  provide  an  overview  of   the  current  
literature about esophageal motility dysfunctions in 
patients  with  gastroesophageal  reflux  disease.  Esopha-
geal manometry, by recording intraluminal pressure, 
represents the gold standard to diagnose esophageal 
motility  abnormalities.   In  particular,  using  novel   tech-
niques, such  as  high   resolution  manometry  with  or  
without  concurrent  intraluminal  impedance  monitoring,  
transient  lower  esophageal  sphincter  (LES)  relaxations,  
hypotensive  LES,  ineffective  esophageal  peristalsis  and  
bolus transit abnormalities have been better defined 
and  strongly  implicated  in  gastroesophageal  reflux  dis-
ease  development.  Overall,  recent  findings  suggest  that  
esophageal motility abnormalities are increasingly prev-
alent  with   increasing  severity  of   reflux  disease,   from  
non-erosive reflux disease to erosive reflux disease 
and  Barrett’s  esophagus.  Characterizing  esophageal  
dysmotility  among  different  subgroups  of  patients  with  
reflux  disease may represent a fundamental approach 
to properly diagnose these patients and, thus, to set up 
the  best   therapeutic  management.  Currently,  surgery  
represents  the  only  reliable  way  to  restore  the  esoph-
agogastric junction integrity and to reduce transient 
LES  relaxations  that  are  considered  to  be  the  predomi-
nant  mechanism  by  which  gastric  contents  can  enter  
the  esophagus.  On  that  ground,  more   in  depth  future  
studies assessing the pathogenetic role of dysmotility in 
patients  with  reflux  disease  are  warranted.
©  2014  Baishideng  Publishing  Group  Co.,  Limited.  All   rights  
reserved.
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Core tip: Esophageal motility abnormalities are among 
the main factors implicated in the pathogenesis of gas-
troesophageal   reflux  disease.   In  particular,   transient  
lower  esophageal  sphincter  (LES)  relaxations,  hypoten-
sive  LES,   ineffective  esophageal  peristalsis  and  bolus  
transit abnormalities have been strongly implicated in 
gastroesophageal  reflux  disease  development.  Moreo-
ver, recent findings suggest that these abnormalities 
are   increasingly  prevalent  with   increasing  severity  of  
REVIEW
Online Submissions: http://www.wjgnet.com/esps/
wjgpt@wjgnet.com
doi:10.4292/wjgpt.v5.i2.86
86 May 6, 2014|Volume 5|Issue 2|WJGPT|www.wjgnet.com
World J Gastrointest Pharmacol Ther  2014 May 6; 5(2): 86-96
ISSN 2150-5349 (online)
© 2014 Baishideng Publishing Group Co., Limited. All rights reserved.
reflux  disease.  Currently,  surgery  represents   the  only  
reliable  way   to   restore   the  esophagogastric   junction  
integrity  and  to   reduce   transient  LES  relaxations.  On  
that ground, more in depth future studies assessing the 
pathogenetic  role  of  dysmotility   in  patients  with  reflux  
disease  are  warranted.
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INTRODUCTION
Gastroesophageal reflux disease (GERD) develops when 
the reflux of  gastric contents into the esophagus leads to 
troublesome symptoms, such as heartburn and regurgita-
tion, with or without mucosal damage and/or complica-
tions[1]. Population-based studies indicate that GERD is a 
highly prevalent condition in Western countries[2]. How-
ever, these patients are markedly heterogeneous in terms 
of  clinical features, pathophysiological mechanisms and 
response to acid suppression, including Barrett’s esopha-
gus (BE), erosive esophagitis (ERD) and non-erosive 
reflux disease (NERD)[3-8]. Of  note, the pattern of  es-
ophageal motility has been shown to differ in the various 
subclasses of  GERD patients[4]. 
The pathogenesis of  GERD is multifactorial, involv-
ing transient lower esophageal sphincter (LES) relaxations 
(TLESRs) as well as other LES pressure abnormalities (i.e., 
hypotensive LES)[9]. Moreover, other factors contributing 
to the pathophysiology of  GERD include impairment 
of  the esophagogastric junction (EGJ) (i.e., hiatal hernia), 
ineffective esophageal acid and bolus clearance, delayed 
gastric emptying and impaired mucosal defensive fac-
tors[9,10]. 
The recent advent of  new technologies, such as 
combined impedance-manometry and high-resolution 
manometry (HRM), has represented a major advance in 
defining and characterizing esophageal motility abnor-
malities in GERD patients[11,12].
The present article intends to appraise and critically 
discuss the current literature about esophageal motility 
dysfunctions in patients with GERD.
MOTILITY ABNORMALITIES IN GERD
The anti-reflux barrier, consisting of  LES, crural dia-
phragm (CD), angle of  His and normal thorax-abdomen 
pressure gradient, prevents reflux of  gastric contents 
into the esophagus, whereas esophageal peristalsis helps 
to clear the refluxate and reduce exposure to noxious 
components of  gastric juice. Consequently, impairment 
of  both EGJ, including LES and CD, and/or esophageal 
clearance may favor GERD[10]. The main motility ab-
normalities contributing to the occurrence of  refluxes in 
GERD are impairment of  the EGJ (i.e., TLESRs, hypo-
tensive LES, anatomic distortion of  the EGJ) and inef-
fective esophageal motility (IEM). 
Impairment of the EGJ
In this context, TLESRs are considered to be the pre-
dominant mechanism by which gastric contents can enter 
the esophagus[13]. According to Spechler and Castell crite-
ria, using conventional manometry testing, TLESRs were 
defined as periods, lasting 10-60 s, of  spontaneous (non 
preceded by a swallow) LES relaxation[14]. In patients 
with reflux, up to 75% of  reflux events occur during 
TLESRs, but the proportion of  reflux episodes that can 
be attributed to TLESRs decreases inversely with respect 
to the severity of  GERD, probably due to the increasing 
prevalence of  hypotensive LES in patients with severe 
GERD[15-19]. In addition, TLESRs appear to play a less 
important role for reflux episodes in patients with hiatal 
hernia than in patients without hiatal hernia[15]. Hypoten-
sive LES is diagnosed when LES basal pressure is less 
than 10 mmHg and represents another major determi-
nant for the EGJ incompetence[20]. Of  note, the mean 
resting LES pressure was found to be significantly lower 
in patients with ERD than in those with NERD[21,22] and 
patients with BE and ERD, thus a higher severity of  
GERD usually has the highest frequency of  hypotensive 
LES[16,17]. Anatomic degradation of  the EGJ was also ob-
served to play a role in the genesis of  reflux events. Pan-
dolfino et al[23] observed that the opening characteristics 
of  the relaxed EGJ during low-pressure distention were 
different between GERD patients and normal subjects, 
that is a wider opening in GERD patients than in nor-
mal controls. Such a difference could not be explained 
entirely by presence of  an axial hiatus hernia or by altera-
tions in LES pressure. Thus, mechanical degradation of  
the EGJ other than hiatal hernia distinguishes GERD pa-
tients from normal subjects (i.e., competence of  the CD, 
integrity of  the phrenoesophageal ligament, alterations in 
the muscular wall of  the LES)[23]. 
Ineffective esophageal motility
Impaired esophageal clearance can be caused by IEM, 
such as ineffective peristalsis or failed peristalsis[24,25]. In 
2001, using conventional manometry, IEM was defined 
as distal esophageal hypocontractility in ≥ 30% of  wet 
swallows, characterized either as contraction amplitude < 
30 mmHg in the distal esophagus, 3 and 8 cm above the 
LES, or as peristaltic waves that are not propagated to the 
distal esophagus, or absent peristalsis[14]. Hypocontractil-
ity is considered the most prevalent esophageal motor 
disorder in GERD[26,27] and this concept has been further 
supported by different studies showing that esophageal 
peristaltic dysfunction was increasingly prevalent with 
more severe GERD presentation[16,19,26,28]. Of  note, in a 
group of  patients with respiratory symptoms associated 
with reflux, IEM was found in 53% of  asthmatics, 41% 
of  chronic coughers and 31% of  those with laryngitis[29]. 
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Recently, studies carried out in patients with sclero-
derma, who are characterized by failed or absent peri-
stalsis and low basal LES pressure, observed that these 
patients are frequently affected by GERD and its com-
plications[30-32], thus substantiating the relevant role of  
esophageal clearance for the development of  GERD.
As reported in the next section, HRM, with or with-
out concurrent intraluminal impedance monitoring, al-
lows a more complete definition of  peristalsis that is, at 
least in part, highlighted in the Chicago Classification[33]. 
ADVANCES IN THE DIAGNOSIS OF GERD 
MOTILITY ABNORMALITIES
Esophageal manometry, by recording intraluminal pres-
sure, represents the gold standard to diagnose esophageal 
motility abnormalities. Until recently, stationary esopha-
geal manometry was performed using an intraluminal 
catheter with four to eight water-perfused channels con-
nected to external pressure sensors, including a sleeve 
sensor to measure continuously the maximum LES pres-
sure[34,35]. 
Although the diagnosis of  esophageal motility disor-
ders is based on manometric findings, it is worth noting 
that endoscopy represents an important diagnostic tool 
to identify specific causes of  motility disorders (i.e., diver-
ticulum, mechanical obstruction, eosinophilic esophagi-
tis)[36-38]. 
High-resolution manometry
HRM is a recently developed technique using multiple (up 
to thirty-six) closely spaced pressure sensors to measure 
intraluminal pressure changes of  the entire esophagus 
during swallowing[39]. Indeed, a dynamic representa-
tion of  pressure variations is recorded from the upper 
esophageal sphincter to the lower one, providing an es-
ophageal pressure topography study[40]. Of  note, a new 
practical classification of  esophageal motor disorders, the 
Chicago Classification[33], has been developed using sev-
eral esophageal pressure topography metrics, constructed 
from HRM data, able to thoroughly characterise tests 
swallows[41,42]. Moreover, HRM-based studies improved 
both EGJ and TLESRs assessment and underlined their 
role as main mechanisms involved in the development of  
reflux events[43,44]. 
As already known, GERD is primarily a motility 
disorder in which TLESRs plays a crucial role[45] and, in 
this regard, recent evidence has highlighted that HRM is 
reproducible and more sensitive than stationary manom-
etry to detect TLESRs associated with refluxes (Figure 
1A), also providing a better interobserver agreement[46-47]. 
HRM data from patients with esophageal symptoms (dys-
phagia, chest pain and heartburn/regurgitation), com-
pared to asymptomatic volunteers, revealed that measur-
ing the duration of  the esophageal low pressure zone, in 
the area of  transition from striated to smooth muscle, as 
defined by the time delay between the proximal and dis-
tal esophageal contraction waves, might be a meaningful 
variable in GERD and dysphagia[48]. To date, using HRM 
with esophageal pressure topography, the definition of  
TLESRs has been further detailed (Table 1)[43,49,50]. 
Regarding the EGJ assessment, HRM provides a 
dynamic representation of  the EGJ high-pressure zone, 
making it possible to isolate the extrinsic CD contrac-
tion from expiratory LES pressure[51]. On this basis, 
Pandolfino et al[51] reported that reduced inspiratory EGJ 
pressure augmentation, an indicator of  impaired CD 
function, was a common finding in GERD patients and 
a better predictor of  GERD prevalence than either LES 
pressure or LES-CD separation (the HRM signature of  
hiatus hernia). By means of  HRM monitoring, it is pos-
sible to document the presence of  hiatal hernia measur-
ing simultaneously the separation between the intrinsic 
LES and CD[52]. Bredenoord et al[15] showed that, in pa-
tients with a small hiatal hernia, temporal reduction of  
the hernia occurs frequently. During spatial separation 
of  the diaphragm and LES, reflux events occurred more 
often than during reduction of  the hernia[15]. Overall, the 
defects of  the EGJ can be evaluated in more detail by 
means of  HRM monitoring and, thus, future studies will 
better clarify the role of  EGJ morphology in GERD de-
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  TLESRs: periods (lasting more than 10-60 s) of spontaneous LES relaxation characterized by:
     (i) absence of swallowing for 4 s before to 2 s after the onset of LES relaxation,
     (ii) relaxation rate of ≥ 1 mmHg/s
     (iii) time from onset to complete relaxation of ≤ 10 s
     (iv) nadir pressure of ≤ 2 mmHg
      LES relaxations associated with a swallow and fulfilling the above mentioned criteria (ii), (iii) and (iv) that lasted more than 10 s are considered as TLESR
  Esophagogastric junction:
     Type 1: no separation between the LES and the crural diaphragm
     Type 2: minimal separation (> 1 and < 2 cm) making for a double-­peaked pressure profile that is not yet indicative of hiatal hernia
     Type 3: more than 2 cm separation between the LES and the crural diaphragm at inspiration so that two high-­pressure zones can be clearly identified
        3a: respiratory inversion point distal to the LES
        3b: respiratory inversion point proximal to the LES
  Weak peristalsis with large (a) and small peristaltic defects (b):
     (i) Mean integrated relaxation pressure < 15 mmHg and > 20% swallows with large breaks in the 20 mmHg isobaric contour ( > 5 cm in length)
     (ii) Mean integrated relaxation pressure < 15 mmHg and > 30% swallows with small breaks in the 20 mmHg isobaric contour (2–5 cm in length)
Table 1  Manometric criteria for esophageal motility associated with gastroesophageal reflux disease
LES: Lower esophageal sphincter; TLESRs: Transient lower esophageal sphincter relaxations.
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sis, occurred more frequently in patients with unexplained 
non-obstructive dysphagia than in control subjects[53]. 
In addition, it has been demonstrated that HRM pre-
dicts bolus movement more accurately than conventional 
manometry and identifies clinically relevant esophageal 
dysfunction not detected by other investigations, includ-
velopment and progression (Table 1).
As for the esophageal peristalsis, a recent HRM study 
aimed at developing a classification of  weak peristalsis in 
esophageal pressure topography, showed that large (> 5 
cm) and small (2-5 cm) pressure troughs in the 20 mm 
Hg isobaric contour of  peristalsis, but not failed peristal-
Figure 1  Portion of high-resolution impedance manometry tracing. A: Showing an example of transient lower esophageal sphincter relaxation and impedance-
detected  gastroesophageal  reflux  event  with  secondary  peristaltic  wave;;  B:  Showing  an  example  of  complete  bolus  transit  during  a  peristaltic  swallow.
A
B
Secondary
peristalsis
Impedance-detected
gastro-esophageal
reflux  episode
Transient  lower
esophageal relaxation
OGJ  =  lower  oesophgeal
Sphincter + crural diaphragm
Upper esophageal sphincter
HRM  swallow  with
normal peristalsis
Impedance
normal bolus
transit
OGJ  =  lower  oesophgeal
Sphincter + crural diaphragm
Stomoach
Stomoach
Esophagus
Esophagus
Pharynx
Pharynx
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ing conventional manometry[54]. 
Combined impedance-manometry
The application of  combined impedance-manometry 
technology provides relevant additional data regarding 
esophageal motility compared to conventional manom-
etry[55], particularly to identify abnormal bolus transport 
and clearance during swallows, and to investigate the 
relationships between bolus transit and LES relaxation[12] 
(Figure 1B).
After instillation of  an acid bolus in healthy subjects, 
in which Sildenafil provoked a graded impairment in 
esophageal motility without affecting saliva secretion, 
simultaneous manometry, pH and impedance study 
showed that, during upright acid reflux, volume clearance 
was slightly prolonged only with severe IEM (> 80% 
abnormal peristaltic sequences)[24]. In the supine position, 
severe IEM significantly prolonged chemical and volume 
clearance[24]. In keeping with these results, Fornari et al[25] 
observed that mild IEM did not affect esophageal clear-
ance in GERD patients. Only severe IEM was associated 
with prolonged clearance and acid exposure, particularly 
in supine periods[25]. Recently, we demonstrated that 
an increasing degree of  esophageal mucosal damage in 
GERD patients (ERD and BE) was associated with a 
progressively more severe deflection of  esophageal func-
tion, expressed by an increased frequency of  IEM and 
bolus transit abnormalities, the latter ones also occurring 
in cases of  a normal motility pattern[16]. 
A new study with combined HRM and impedance 
monitoring reported that the frequency of  TLESRs did 
not differ between patients with NERD and healthy con-
trols. In patients with NERD, TLESRs were associated 
more often with reflux episodes than in controls and this 
association increased when only liquid and mixed refluxes 
were considered[56]. If  confirmed in larger series, it might 
be hypothesized that factors involved in the occurrence 
of  reflux in NERD patients during TLESRs are different 
from those in healthy subjects and that the volume of  
refluxate in patients is higher than that in healthy sub-
jects[56]. 
Finally, the importance of  concomitant manometry 
and impedance monitoring in order to distinguish rumi-
nation syndrome from GERD in patients with predomi-
nant regurgitation has been highlighted[57].
DIFFERENCES IN MOTILITY 
ABNORMALITIES AMONG GERD 
SUBGROUPS 
As mentioned above, several studies reported that motor 
abnormalities are increasingly prevalent with the sever-
ity of  GERD, from NERD, ERD to BE[19,21-22,26]. On the 
other hand, there are studies in contrast with these find-
ings, showing no significant difference in terms of  hy-
potensive LES and IEM between NERD and ERD[58-59]. 
However, it should be pointed out that, to assess any dif-
ference in motility dysfunction among GERD subgroups, 
a careful classification is warranted. In particular, the 
inclusion of  patients with reflux symptoms and negative 
upper endoscopy as NERD patients is often made with-
out any attempt of  distinguishing functional heartburn 
(as defined by Rome ? criteria) from NERD by means 
of  pathophysiological investigations. To date, NERD is 
identified as a condition in which typical reflux symptoms 
appear in patients with negative endoscopy and presence 
of  troublesome reflux-associated symptoms (to acid, 
weakly acidic or non-acid reflux)[5], whereas functional 
heartburn is a disorder characterized by symptoms of  
heartburn not related to GERD, as diagnosed by means 
of  24-h impedance-pH testing, and must be distinguished 
from NERD[60-64]. 
In this context, Frazzoni et al[18] showed that the mean 
LES pressure was significantly lower in ERD and NERD 
patients than in controls and functional heartburn pa-
tients and that the mean distal esophageal wave amplitude 
was lower in patients with ERD than in patients with 
NERD, functional heartburn and controls. In addition, 
the authors found that the prevalence of  hiatal hernia 
was significantly higher in ERD and NERD than in func-
tional heartburn and controls[18]. In line with these results, 
we reported that GERD patients have a greater preva-
lence of  abnormally low LES pressure, IEM and hiatal 
hernia compared with patients with functional heartburn 
and healthy controls. In particular, we observed that IEM 
gradually increased from controls and functional heart-
burn to NERD and from ERD to BE patients[16]. By the 
application of  concurrent manometry and impedance 
study, it has been shown that ERD is characterized by 
longer esophageal bolus transit and fewer complete bolus 
transit than NERD and healthy controls. The authors 
hypothesized that the noted differences in esophageal 
bolus transit might reflect a continuum of  dysfunction 
secondary to increasing esophageal mucosal damage[65]. 
On the other hand, a recent HRM study reported a peri-
staltic dysfunction in 56% of  NERD and 76% of  ERD 
patients, with no significant difference between the two 
groups[66]. Nevertheless, the authors observed that, using 
HRM, the frequency of  esophageal motility abnormali-
ties in GERD was higher than that reported in a previous 
study performed with conventional manometry[66]. 
It is also worth noting the possibility that reflux-
induced esophageal contractions can be responsible for 
symptom perception. Indeed, Pehlivanov et al[67], while 
studying 12 unclassified subjects with heartburn by means 
of  24-h pH-metry, combined with synchronized pressure 
recording and high-frequency intraluminal ultrasound 
imaging of  the esophagus, highlighted a close correlation 
between heartburn episodes, associated with acid reflux or 
not, and abnormally long durations of  longitudinal mus-
cle contractions. Afterwards, in 10 unclassified subjects 
complaining of  chronic heartburn, Bhalla et al[68] observed 
that an increase in symptom sensitivity, elicited by acid in-
fusion, occurred in concomitance with a perturbation of  
esophageal contractility, as revealed by a greater increase 
in contraction amplitude, contraction duration, muscle 
thickness and incidence of  sustained esophageal contrac-
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tions during the second acid infusion, in comparison with 
the first one. On the other hand, Thoua et al[69] showed 
that acid infusions, although inducing greater acid sensi-
tivity in NERD patients compared to ERD patients and 
controls, did not induce any changes in the amplitude 
of  esophageal contractions in any of  the studied patient 
groups.
Overall, further studies with advanced techniques 
such as HRM and proper physiological classification of  
patients with reflux symptoms are needed in order to bet-
ter assess the prevalence and pathophysiological role of  
esophageal motility abnormalities in GERD patients.
TREATMENT PERSPECTIVES
Studies using impedance-pH monitoring have demon-
strated that 30%-40% of  GERD patients have persistent 
symptoms despite proton pump inhibitor therapy, mostly 
related to non-acid reflux events[70,71]. In keeping with 
this assumption and considering that TLESRs represent 
the main pathogenetic mechanism of  all types of  reflux 
events, controlling the occurrence of  TLESRs is consid-
ered to be a relevant therapeutic goal in GERD manage-
ment. However, the actual therapeutic options are limited 
because there is no specific pharmacological intervention 
that reliably restores LES function. Drugs interfering 
with TLESRs, called reflux inhibitors, have been devel-
oped, including: -aminobutyric acid (GABA)B-receptor 
agonists (baclofen, lesogaberan, arbaclofen placarbil) 
and antagonists to the metabotropic glutamate receptor 
5 (ADX10059). Despite the promising initial results of  
these compounds[72-74], their clinical use has been com-
promised by various side effects or small therapeutic 
gain[75-77]. 
The use of  prokinetic drugs (i.e., metoclopramide, 
bethanecol, domperidone) is supposed to accelerate gas-
tric emptying, increase LES tone and hasten esophageal 
clearance. However, the currently available prokinetics are 
poorly effective in treating GERD-related dysmotility[78,79] 
and compounded by side effects[80,81]. 
Considering the lack of  specific effective drugs on 
reflux-related esophageal dysmotility, dietary and lifestyle 
interventions are strongly suggested. Particularly, weight 
loss, head of  bed elevation and left lateral decubitus posi-
tion provided an improvement in GERD measures[82]. 
Reduction in calorie density and a low-fat diet has posi-
tive effects respectively on acid exposure after a meal 
and on the frequency of  reflux symptoms[83]. In addition, 
chewing gum for half  an hour after meals could reduce 
acidic postprandial esophageal reflux, likely stimulating 
salivation and swallowing, and thus improving both vol-
ume and chemical clearance[84]. 
Currently, surgery represents the only reliable way to 
treat esophageal motility abnormalities. Indeed, fundo-
plication is able to reduce both the volume of  proximal 
stomach and the rate of  TLESRs[85-88]. Particularly, the 
percentage of  TLESRs associated with reflux was found 
to be decreased after fundoplication[85,89]. In addition, sur-
gery is able to restore the eventual EGJ disruption acting 
on a hiatal hernia, CD defects and gastroesophageal high 
pressure zone[89]. Pandolfino et al[90] showed that anti-
reflux surgery decreases the distensibility of  the EGJ to 
a level similar to normal subjects. Recently, the LOTUS 
trial, a 5-year randomized, open, parallel-group trial, 
showed that the remission rate did not differ between 
optimized esomeprazole therapy (92%) and standardized 
laparoscopic anti-reflux surgery (85%) in GERD patients 
(Log-Rank P = 0.048)[91]. However, at 5 years, acid regur-
gitation was more prevalent in the esomeprazole group 
than in the anti-reflux surgery group;; whereas dysphagia, 
bloating and flatulence were more prevalent in the anti-
reflux surgery group[91]. Moreover, both treatments were 
well tolerated, with similar safety profiles[91]. Overall, the 
positive effects of  anti-reflux surgery have been clearly 
demonstrated, not only on reflux symptoms[91-93] but also 
on dysphagia[94-96]. However, in this context, performing 
manometry to exclude severe motility abnormalities dur-
ing the preoperative assessment of  patients being con-
sidered for anti-reflux surgery is warranted[35]. As to the 
best surgical procedure to adopt, a systematic review and 
meta-analyses comparing the effects of  laparoscopic Nis-
sen (360°) and Toupet (270°) fundoplication for GERD 
have assessed that both procedures are equally effective 
with respect to the percentage of  patients with recurrent 
pathological acid exposure (RR = 1.26, P = 0.29) and 
subjective reflux recurrence (RR = 1.11, P = 0.61)[92]. In 
contrast, the Nissen procedure was associated with higher 
prevalence of  postoperative dysphagia (13.5% vs 8.6%, 
P = 0.02)[92]. On the other hand, another meta-analysis 
reported that the Toupet procedure was more likely to 
result in surgery-related complications during the early 
post-operative period (P = 0.04)[97]. 
In the last decade, a variety of  endoscopic techniques 
(i.e., radiofrequency ablation, suturing devices) have been 
proposed as less invasive and costly alternatives to lapa-
roscopic surgery, even although many methods are no 
longer available primarily because of  unacceptable side 
effects, modest or lack of  long-term efficacy, cost, time 
invested and lack of  reversibility[98-100]. To our best knowl-
edge, currently available anti-reflux endoscopic devices 
include the Stretta procedure (Mederi Therapeutics, Inc, 
Greenwich, CT), the EsophyX transoral incisionless fun-
doplication (EndoGastro Solutions, Redmond, WA) and 
the Endoscopic Plicator (former distributor NDO Sur-
gical, Inc., Mansfield, MA, United States;; current prod-
uct of  Ethicon Endosurgery, Sommerville, NJ, United 
States). The Stretta procedure is an example of  a ther-
mal ablation technique for reflux control that has been 
supposed to be effective in decreasing esophageal acid 
sensitivity without significant effect on esophageal acid 
exposure[101-103]. However, a recent review article showed 
that, in selected GERD patients, Stretta reduces esopha-
geal acid exposure, decreases the frequency of  TLESRs, 
increases patient satisfaction, decreases medication use 
and improves quality of  life[104]. In GERD patients with 
a small or no hiatal hernia, transoral incisionless fundo-
plication has been shown to reduce the number of  post-
prandial TLESRs, the number of  TLESRs associated 
Martinucci I et al .  Motility  abnormalities  and  reflux  disease
92 May 6, 2014|Volume 5|Issue 2|WJGPT|www.wjgnet.com
with reflux and EGJ distensibility. This resulted in a 
reduction of  the number and proximal extent of  reflux 
episodes and improvement of  acid exposure in the up-
right position after 6 mo[105]. In addition, previous studies 
have shown that this procedure permits an increase in 
LES length and resting pressure and is able to normalize 
esophageal acid exposure in GERD patients, improving 
reflux symptoms and quality of  life, and reducing PPI 
use[106]. Endoscopic treatment by full-thickness plication 
using the Endoscopic Plicator has been shown to sig-
nificantly reduce GERD symptoms, PPI use and distal 
esophageal acid exposure in both prospective open-label 
and randomized controlled trials[107,108]. Recently, a novel 
Plicator device able to place multiple sutures has been 
applied, showing that this technique is safe and effective 
in reducing GERD symptoms, medication use and es-
ophageal acid exposure at 12 mo follow-up without clini-
cal significant side-effects[109,110]. Overall, considering the 
feasibility and safety profiles that are similar to those of  
anti-reflux surgery, endoscopic techniques appear to be 
procedures of  interest for GERD;; however, they are not 
as effective as surgery for returning acid exposure to nor-
mal, healing esophagitis and resolution of  symptoms[111]. 
Thus, widespread use of  these techniques cannot be rec-
ommended yet and further controlled prospective trials 
are urgently required. 
Finally, an alternative surgical method to augment 
LES function has been assessed with a magnetic ring 
device that is laparoscopically placed around the external 
diameter of  the distal esophagus, the LINX reflux man-
agement system, with encouraging results in eliminating 
reflux symptoms and normalizing esophageal acid expo-
sure[112]. As with the endoscopic techniques, the LINX 
device is not able to treat the anatomical abnormality of  
a large hiatus hernia. In conclusion, further controlled 
prospective studies with long-term follow-up comparing 
the LINX device to standard pharmacological and surgi-
cal alternatives are needed. 
CONCLUSION
The pathogenesis of  GERD is multifactorial, including 
esophageal motility abnormalities of  which the most 
important are TLESRs, hypotensive LES and IEM. 
High-resolution manometry, with or without concur-
rent intraluminal impedance monitoring, providing an 
esophageal pressure topography study of  the esophagus, 
allows a more complete definition of  esophageal peristal-
sis. Moreover, HRM-based studies improved both EGJ 
and TLESRs assessment as a pathophysiological mecha-
nism for the occurrence of  reflux events. Particularly, the 
combination of  esophageal manometry and intraluminal 
impedance measurement allows assessment of  abnormal 
bolus transport and clearance during swallows and inves-
tigation of  the relationships between bolus transit and 
LES relaxation. On that ground, more in depth future 
studies assessing the pathogenetic role of  dysmotility in 
GERD patients are warranted.
To date, the majority of  studies in this field report 
that these esophageal motility abnormalities are increas-
ingly prevalent with increasing severity of  GERD, thus 
from NERD, to ERD and BE patients. A more compre-
hensive diagnosis and characterization of  reflux patients 
with esophageal dysmotility is nowadays possible and 
this additional information may be of  help in identifying 
patients who could potentially benefit more from sur-
gery due to restoration of  OGJ integrity or reduction of  
TLESRs.
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